Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-09-29

Clinical Trial Update: Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial comparing brand-name versus generic alendronate for osteoporosis evaluated efficacy and safety; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Brand alendronate (alendronate)
  • Generic alendronate (alendronate)

Snippet

Sponsor: Mahidol University | Conditions: Osteoporosis | Phase 4 | Status: COMPLETED | Results posted: 2021-09-29